Cabaletta Bio CABA 深 沪
已收盘 11-06 16:00:00 美东时间
1.30
+0.020
+1.56%
华盛通- 最 高1.335
- 今 开1.27
- 成交量 300.25万股
- 最 低 1.25
- 昨 收 1.28
- 总市值 2.20亿
- 52周最高 4.23
- 市盈率 静 --
- 换手率 1.77%
- 52周最低 1.18
- 委 比 -86.34%
- 总股本 1.70亿
- 历史最高 26.35
- 量 比 0.69
- 振 幅 6.64%
- 历史最低 0.59
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
Cabaletta Bio reported third-quarter 2026 financial results and provided updates on its CAR T-cell therapy, rese-cel, for autoimmune diseases. Key highlights include anticipated topline results for the registrational adult myositis study in H2 2027, with a BLA submission planned for myositis in 1Q 2028. The company is also advancing trials in juvenile dermatomyositis, systemic sclerosis, and other autoimmune conditions. Cabaletta extended its ope...
11-05 12:30
Cabaletta Bio to Participate in Upcoming Investor Conferences
Cabaletta Bio, a biotech company focused on developing curative cell therapies for autoimmune diseases, announced its participation in two upcoming investor conferences: Guggenheim’s 3rd Annual Healthcare Innovation Conference on November 10, 2026, in Boston, and the 2026 Jefferies Global Healthcare Conference in London on November 18, 2026. Both events will feature webcasted fireside chats accessible via the company’s website. Cabaletta Bio spec...
11-03 13:00
Cabaletta Bio收跌5.3%，成交额812.16万美元
11月3日，Cabaletta Bio（CABA）收跌5.3%，报1.43美元，成交额812.16万美元，市值2.42亿美元。 行情数据 • 开盘价：1.52美...
11-03 07:32
Cabaletta Bio收跌8.16%，成交额847.5万美元
10月27日，Cabaletta Bio（CABA）收跌8.16%，报1.35美元，成交额847.5万美元，市值2.29亿美元。 行情数据 • 开盘价：1.4...
10-27 06:36
Cabaletta Bio收跌9.03%，成交额972.92万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:38
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cabaletta Bio granted inducement equity awards to four new non-executive employees, including stock options for 385,000 shares at varying prices ($2.46, $2.00), vesting over four years. The company focuses on developing curative cell therapies for autoimmune diseases, with its lead candidate, rese-cel, in clinical trials across multiple therapeutic areas.
10-05 20:01
美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $16 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $16 price target.
09-02 01:15
Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday. Shares of Cango Inc (NYSE:CANG) fell sharply in pre-market trading as the company posted downbeat results for the second quarter. Cango reported quarterly losses of $1.99 per share which missed the...
09-01 20:02
三例死亡！诺华踩下CAR-T自免急刹车
近日，诺华因3例罕见的免疫效应细胞相关噬血细胞综合征（IEC-HS）死亡病例，紧急叫停八项自免临床试验；BMS则因常规监测中发现短暂且可逆的炎症事件，出于充分审...
09-01 16:31
